Effect of Diabetes Mellitus on Cholesterol Metabolism
NCT00879710 is an interventional trial sponsored by Medical College of Wisconsin. As of 21 Nov 2026, it is completed. It studies Simvastatin or ezetimibe in Hypercholesterolemia, Type 1 Diabetes Mellitus and 1 more condition. The registry lists an enrollment of 57 participants at 1 site in 1 country. The registry lists a start date of 31 Aug 2008 and a primary completion date of 31 Jul 2013.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00879710 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Medical College of Wisconsin |
| Enrollment | 57 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Hypercholesterolemia, Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus |
| Drugs | Simvastatin or ezetimibe |
| Start | 31 Aug 2008 |
| Primary completion | 31 Jul 2013 |
| Study completion | 31 Jul 2013 |
| Last update posted | 29 Jul 2020 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Shailendra B Patel, MD, PhD
Medical College of Wisconsin
Principal Investigator - Srividya Kidambi, MD
Medical College of Wisconsin
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medical College of Wisconsin /froedtert Hospital
Milwaukee
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT00879710
Each answer restates registry values shown on this page.
What is NCT00879710?
NCT00879710 is an interventional trial sponsored by Medical College of Wisconsin. It studies Simvastatin or ezetimibe in Hypercholesterolemia, Type 1 Diabetes Mellitus and 1 more condition.
Who leads NCT00879710?
The registry names Shailendra B Patel, MD, PhD (principal investigator, Medical College of Wisconsin) and Srividya Kidambi, MD (principal investigator, Medical College of Wisconsin) as overall officials.
Where does NCT00879710 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT00879710 study?
The registered drug and biological interventions are Simvastatin or ezetimibe.
When did NCT00879710 end?
The registry lists a primary completion date of 31 Jul 2013 and a study completion date of 31 Jul 2013. The sponsor last updated the record on 29 Jul 2020.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.